mercoledì 11 gennaio 2017

Next Steps in Absolute Prohibition

 

Next Steps in Absolute Prohibition

Some of us have been meeting in Google Hangouts to discuss next steps.  If you support the absolute prohibition of involuntary commitment and involuntary treatment, you are welcome to participate in sharing information and exploring strategies. Please contact info@chrusp.org for details.
We are planning to post additional materials on this site about good practices in law reform and alternatives, and about projects at national level and otherwise that we are involved in, related to the aim of absolute prohibition.

Allies, Step Up Please!



Allies, Step Up Please!

by chrusp
This post is addressed especially to mental health professionals and researchers, including psychiatrists, social workers, therapists, and also to lawyers and law professors.
If you have spoken against coercive practices, if you are critical of the medical model and are willing to envision with us a world where support and services *never* mean paternalism or coercion, your voice is needed for two reasons.  First, to counter the backlash the UN Convention on the Rights of Persons with Disabilities has faced from organized psychiatry (for example here and here) and its apologists in the legal field (sorry but I can't bring myself to search further through the muck).  And second, to bring your knowledge and skills to the work of transformation to bring this new world into being.
The existence of the CRPD and its jurisprudence establishing the absolute prohibition of commitment and forced treatment, along with that of the Working Group on Arbitrary Detention (all linked in the Call to Action), by creating a new legal norm and obligation on governments, creates space for these positions to be sayable in the mainstream, and for the work to take place.
Also significant, though I had not thought of including it in the Campaign materials earlier, is a statement of two UN Special Rapporteurs, the Special Rapporteur on the rights of persons with disabilities and the Special Rapporteur on the right to health, entitled: "Dignity must prevail" - An appeal to do away with non-consensual psychiatric treatment World Mental Health Day - Saturday 10 October 2015.  They said:
Dignity cannot be compatible with practices of force treatment which may amount to torture. States must halt this situation as a matter of urgency and respect each person’s autonomy, including their right to choose or refuse treatment and care.
Without freedom from violence and abuse, autonomy and self-determination, inclusion in the community and participation in decision-making, the inherent dignity of the person becomes an empty concept.  The international community needs to acknowledge the extent of these violations, which are broadly accepted and justified in the name of psychiatry as a medical practice.
The concept of ‘medical necessity’ behind non-consensual placement and treatment falls short of scientific evidence and sound criteria. The legacy of the use of force in psychiatry is against the principle ‘primum non nocere’ (first do no harm) and should no more be accepted.
Please join survivors and allies who are speaking out as human rights defenders, to defend and strengthen the work of the UN mechanisms that are promoting and protecting the right to be free from all forms of commitment and forced treatment.

giovedì 5 gennaio 2017

In California contro il TSO! Southern California Against Forced Treatment - Kickoff Meeting!



L'immagine può contenere: nuvola, cielo e sMS

https://www.facebook.com/events/1085836134862355/ 

 Unitevi a noi per celebrare l'inizio Contro il Trattamento Sanitario Obbligatorio nella California del Sud! Nel corso di questo primo incontro voglaimo conoscerci e discutere i programmi iniziali per aver sostenere i diritti civili, l'autodeterminazione e la libertà di tutte le persone
 Join us to celebrate the kickoff of Southern California Against Forced Treatment! During this initial meeting we will get to know one other and discuss initial plans for advocating for the civil rights, self-determination, and liberty of all people.

Not a chemical imbalance: Reality behind closed doors

Not a chemical imbalance: Reality behind closed doors: From

Gli antidepressivi sono pericolosi


L'immagine può contenere: una o più persone e sMS
GLI ANTIDEPRESSIVI SONO PERICOLOSI - DISFUNZIONI SESSUALI DOVUTI ALLE SSRI (INIBITORI SELETTIVI DELLA RICAPTAZIONE DELLA SEROTONINA) - NON PIU' MENTE ACUTA - NON PIU' SESSO - NON PIU' AMORE - PENSACI DUE VOLTE!!! PUO' DIVENTARE PERMANENTE

Not a chemical imbalance: Reality behind closed doors

Not a chemical imbalance: Reality behind closed doors: From

martedì 3 gennaio 2017

Question Man - L'uomo domanda - by Irit Shimrat



Eoni fa, quando avevo 25 anni, l’unica ambizione che avevo era quella di uccidermi. Nonostante fossi riuscita ad accumulare tutti i segni del successo esteriore – un lavoro, un appartamento, un compagno – ero paralizzata dalla miseria. Non riuscivo a superare il fatto che qualche anno prima ero stata psichiatrizzata quasi a morte.

Non credevo nella psicoterapia, ma, disperata, mi ero messa nelle mani di un tipo anziano e molto dolce che praticava la “programmazione neurolinguistica”. Quasi sempre cercava di farmi andare in trance, ma non ci riusciva. Una volta mi ha messo a testa in giù, prendendomi per le caviglie e usando un’imbracatura sospesa dal ramo di un albero; mi aveva assicurato che oscillare avanti e indietro dolcemente, avrebbe corretto il mio respiro e i miei problemi psicologici sarebbero miracolosamente evaporati. Un’altra volta mi aveva lasciato fumare uno spinello nel suo studio, con la sua amica infermiera che mi osservava e prendeva appunti. Ho apprezzato il tempo e gli sforzi considerevoli che ha impiegato nel tentativo di aiutarmi, però non mi hanno fatto per niente bene.

Guardando indietro, l’unica cosa che poteva aver avuto qualche senso era chiedermi:

“Come faresti a capire di stare bene?

Senza esitazione ho risposto: “Starei scrivendo.

Mi hanno insegnato a scrivere prima di iniziare la scuola. A sei anni ho sfornato libretti che trattavano di principesse, animali e tutto ciò che riguarda una bambina di sei anni.

On being "normal" by Reshma Valliapan


http://www.thehindu.com/news/cities/Delhi/on-being-normal/article4721175.ece

A young woman diagnosed with schizophrenia recounts the discrimination she faced and the stigma attached to the medical condition in public psyche

I remember my first instance of discrimination, which took place in the very place that existed to understand people like me. I was 21 and had gone in for a psychological test that was being conducted by senior students of psychology.
There was a range of experiments they wanted me to participate in, in order to measure my abilities at problem solving, my memory, my attention span, and so on. I completed the experiments before the minimum time limit and came out. The report said: “We can’t use her scores, they are not normal.”

mercoledì 28 dicembre 2016

Is Pharma Running Out of Brainy Ideas?


              
Cover image expansion
 Summary
              On 4 February, GlaxoSmithKline (GSK) announced that it planned to pull the plug on drug   discovery in some areas of neuroscience, including pain and depression. A few weeks later, news came that AstraZeneca was closing research facilities in the United States and Europe and ceasing drug-discovery work in schizophrenia, bipolar disorder, depression, and anxiety. These cutbacks by two of the top players in drug development for disorders of the central nervous system have raised concerns that the pharmaceutical industry is pulling out, or at least pulling back, in this area. In direct response to the cuts at GSK and AstraZeneca, the Institute of Medicine Forum on Neuroscience and Nervous System Disorders organized a meeting in late June that brought together leaders from government, academia, and private foundations to take stock. But the biggest problem, researchers say, is that there is almost nothing in the pipeline that gives any hope for a transformation in the treatment of mental illness. That's worrying, they say, because the need for better treatments for neurological and psychiatric disorders is vast. Hundreds of millions of people are afflicted worldwide. Yet for some common disorders, like Alzheimer's disease, no truly effective treatments exist; for others, like depression, the existing drugs have limited efficacy and substantial side effects.

Riguardo alla decisione della glaxosmithkline di interrompere le ricerche sugli psicofarmaci, Whitaker, sempre nella sua intervista , dichiara:
 
"......One, the low-serotonin theory of depression has been so completely discredited by leading researchers that maintaining the story with the public has just become untenable. It is too easy for critics and the public to point to the scientific findings that contradict it.
Second, a number of pharmaceutical companies have shut down their research into psychiatric drugs [see Science, 2010], and they are doing so because, as they note, there is a lack of science providing good molecular targets for drug development. Even the drug companies are moving away from the chemical-imbalance story, and thus, what we are seeing now is the public collapse of a fabrication, which can no longer be maintained. In the statement by Dr. Pies, you see an effort by psychiatry to distance itself from that fabrication, putting the blame instead on the drug companies"

...primo, la teoria della diminuzione della serotonina nella depressione è stata completamente screditata portando i ricercatori a dire che è diventato insostenibile mantenere quella storia. Troppo facile per i critici e per il pubblico indicare le scoperte scientifiche che la contraddicono.
Secondo, un numero di compagnie farmaceutiche hanno chiuso con la ricerca di farmaci psichiatrici (Science, 2010, http://science.sciencemag.org/content/329/5991/502.summary) e lo fanno perché, come affermano, la scienza non fornisce bersagli molecolari per lo sviluppo di farmaci. Perfino le case farmaceutiche si stanno defilando dalla storia dello squilibrio chimico, e così, quello che stiamo vedendo è il collasso pubblico di una bugia, che non poteva più stare in piedi. Nell'affermazione del dott. Pies, si vede uno sforzo della psichiatria a distanziati dalla bugia, dando la colpa alle case farmaceutiche..."


a cura di Rossella Biagini

martedì 27 dicembre 2016

Kate Millet - L'inganno della malattia mentale - The Illusion of Mental Illness

  

 

"Siamo anche i sopravvissuti, le vittime e gli oppositori di uno dei più meschini sistemi di oppressione mai sviluppati. Noi siamo quelli che dicono la verità, quando diciamo che la malattia mentale è un abbaglio, dal punto di vista sia intellettuale che scientifico, ma anche un sistema di controllo sociale senza precedenti per rigore e pervasività. Il nostro ruolo è quello di smascherare questo abbaglio e di liberare tutti noi - perché siamo tutti costretti, oppressi, limitati, intimiditi dal fantasma della malattia mentale. Combattiamo con la ragione contro l'errore e la superstizione e con l'immaginazione contro il conformismo e l'oppressione. Che fortuna essere parte di questa lotta per la libertà e i diritti umani."

Kate Millet, 

The Illusion of Mental Illness, in Stastny, Peter; Lehmann, Peter, Alternatives beyond psychiatry, Berlin Eugene, Oregon: Peter Lehmann Publishing, pp. 29–38



“We are also survivors of one of the meanest systems of oppression ever developed, and its victims and its critics. We are the ones to tell the truth, to say that mental illness is an illusion, intellectually and scientifically, but also a system of social control of unprecedented thoroughness and pervasiveness. It is our role to expose this illusion and to free us all - for we are all constrained, oppressed, limited, intimidated by the phantom of mental illness. We stand with reason against error and superstition, with imagination against conformity and oppression. What good fortune to be part of such a struggle for freedom and human rights.” Kate Millet: The Illusion of Mental Illness, in Stastny, Peter; Lehmann, Peter, Alternatives beyond psychiatry, Berlin Eugene, Oregon: Peter Lehmann Publishing, pp. 29–38